Skip to main content

Table 2 Invalid test rates

From: Comparative evaluation of the new FDA approved THxID™-BRAF test with high resolution melting and sanger sequencing

Assay

Invalid test

Invalid rate (%)

HRM (n = 113)

0

0

Sequencing (n = 113)

5

4.4

7500 Fast Dx (n = 113)

1

0.9

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us